VA Backtracks on Controversial Disability Benefits Policy

Joe Wallace

In February 2026, the Department of Veterans Affairs attempted to fast-track a questionable new policy known as the VA “medicated disability rule”.  The backlash from veterans and lobbyists was swift; the Department of Veterans Affairs was essentially shamed into reversing course by an avalanche of negative press, but problems remain in its wake. Especially with the way the new guidelines were to be implemented in the first place.

VA Backtracks on Controversial Disability Benefits Policy

Some veteran advocacy groups complain that the VA bypassed the usual approval process to force the new policy through, invoking emergency powers that some leaders seem eager to use without fully respecting the specific circumstances required to invoke them.

According to the official site of the DAV, the VA’s actions on this rule were “developed and issued in a closed and unnecessarily expedited process that effectively shut out veterans from providing any meaningful input.” What exactly happened?

The Department of Veterans Affairs attempted to revise the medical evaluation of service-connected disabilities. They did this over an eight-day period in February 2026, circumventing the usual process by invoking emergency powers to have the rule published by the Federal Register in a public comment period.

The regular process for such policy changes includes publishing a notice of proposed rulemaking in the Federal Register, followed by a public comment period of up to 60 days.

Then, major policy rules are submitted to Congress for review. This process did not occur in the case of the new “Impact of Medication” rule, and some feel there is little to no justification for pushing the new policy through without complying with the regulations governing such action.

Questions and Answers

What was the specific “medicated disability rule”?

The rule amended federal law to state that VA disability ratings must be based on the “actual level of functional impairment” while a veteran is taking medication. It directed medical examiners not to “estimate or discount” the improvements provided by treatment. If medication reduced a veteran’s symptoms, the rating would be based on that lower level of impairment at the time of the exam.

Why did the VA write this rule in 2026?

Some believe the VA sought to override a 2025 court decision, Ingram v. Collins. In that case, the Court of Appeals for Veterans Claims (CAVC) ruled that the VA must discount the beneficial effects of medication when assigning a rating, unless a specific diagnostic code stated otherwise.

The VA labeled this an “erroneous interpretation” that would have forced the review of over 350,000 pending VA disability claims and created what they described as a massive administrative burden.

How did Secretary Doug Collins use emergency powers to push this through?

Secretary Collins invoked the “good cause” exception of the Administrative Procedure Act to bypass the requirements for standard 60-day public comment and Congressional review periods.

Collins argued that waiting would be “contrary to the public interest” because it would lead to a surge in administrative costs and delayed benefits. By filing it as an Interim Final Rule, he made it legally binding the same day it was published.

What did Secretary Collins say about so-called “fake news” regarding the rule?

On February 19, Collins posted on the social media platform X: “The fake news about the VA’s new medication rule is out of control. We are not cutting benefits; we are clarifying long-standing policy.” But many veterans and lobbyists argue that this statement simply is not true.

Collins maintains, for better or worse, that the rule was simply a clarification of existing practices, despite VSOs arguing that it was a serious departure from established law.

Why was the policy halted so quickly?

The policy was halted primarily due to intense backlash from veterans, advocacy groups, and lawmakers who identified several critical flaws. Critics argued the rule created an incentive for disabled veterans to stop taking life-improving medications to avoid losing their financial stability.

Advocates noted that medication often masks symptoms rather than addressing the underlying injury. A veteran is not “less disabled“ simply because a wheelchair or medication allows them to ambulate or manage pain temporarily. Some lawmakers felt the VA circumvented the normal rulemaking process, denying the public and Congress the chance to review the nearly two billion in projected benefit reductions before they went into effect.

What are the “unforeseen downstream effects” mentioned by critics?

VSO leaders, including those from the VFW, warned that the rule failed to account for the debilitating side effects of many medications, which can be as burdensome as the original disability.

Additionally, they argued the rule ignored the reality that symptoms are often inconsistent; a veteran might appear “well-managed” on the day of an exam despite suffering flare-ups the rest of the month.

What is the current status of the rule for veterans with pending claims?

Enforcement is currently halted, and the VA has stated it will not use the rule “now or in the future.” However, the rule has not been officially pulled from the Federal Register. Legal advocates urge veterans to submit public comments before the April 20, 2026, deadline to ensure the policy is formally and permanently revoked.

Eight-Day VA Policy Timeline

The timeline below shows the VA’s position on its controversial new VA disability rating policy, how it has changed, and what’s possible going forward.

• February 17, 2026, Secretary Doug Collins published the “Evaluative Rating: Impact of Medication” rule as an Interim Final Rule. He used emergency powers to make it effective immediately.
• February 18, 2026, Veterans Service Organizations (VSOs) and members of Congress criticized the rule for penalizing veterans who follow medical treatment plans.
• On February 19, 2026, Secretary Doug Collins labeled criticisms of the rule as “fake news” on social media while simultaneously ordering an immediate halt to its enforcement.
• On February 22, 2026, VA leadership claimed the department would neither enforce nor revisit the rule in the future.
• The formal public comment period for February 24, 2026, remains open through April 20, 2026, though enforcement is currently suspended.

VA Rule Suspended, Not Revoked

The VA could easily invoke the new rule at any time under circumstances applicable at press time, and some veteran advocates fear the VA may do exactly that once the initial anger and bad press over this issue subside.

Does the head of the VA need medical training in order to do the job? Federal law says no. But the current VA secretary seems keen on creating policy that DOES need to be informed by training and context, yet without input from actual trained medical professionals.

New VA Policy Was Already Ruled Against In Court

The situation created a serious conflict for the Department of Veterans Affairs, which had already been ruled against in this area by the U.S. Court of Appeals for Veterans Claims in the 2025 federal case Ingram v. Collins.

The Ingram decision established that the VA must evaluate a veteran’s disability based on its baseline severity, meaning the Board of Veterans’ Appeals must discount the beneficial effects of medication when the specific diagnostic code (DC) does not mention medication. This is in direct opposition to what Doug Collins wanted to push through the system.

The court ruled that if a diagnostic code for a VA-rated condition does not explicitly list medication use as a factor, the VA cannot use a veteran’s improved symptoms while on medication to justify a lower rating.

This is a developing story.